ULTA

Business Profile & Competitive Position

Ulta Beauty, Inc. operates in the Consumer Cyclical sector, specifically in Specialty Retail. It describes itself as a retailer focused on cosmetics, fragrance, skin care, wellness, hair care products, and salon services. The company offers a broad assortment across multiple price points and supports an omnichannel model that includes physical stores, websites, mobile apps, and partnerships. In the U.S., it is the largest specialty beauty retailer, and its international presence includes the Space NK subsidiary in the U.K. and Ireland, a Mexico joint venture, and a Middle East franchise.

The financial numbers support the idea of a structurally advantaged retailer. Net margin is 9.3%, and ROE is 45.4%. A specialty retailer that can sustain a high single-digit net margin while generating a mid-40s ROE is generally doing something more than simply selling inventory; it implies strong brand relevance, disciplined inventory management, and effective capital deployment. Loyalty data is another telling indicator: as of year-end fiscal 2025, Ulta U.S. had more than 46 million loyalty-program members, roughly 95% of total sales came from those members, and omnichannel members historically spent more than three times as much as store-only members. That kind of member concentration can create repeat traffic and richer customer data. The company also has room to expand its U.S. footprint, with management believing more than 1,800 freestanding locations are possible over the long term versus the more than 1,500 stores it operated as of January 31, 2026.

Financial Posture

Ulta Beauty’s current market capitalization is $23.4 billion, and it trades at a P/E of 19.8. Those figures place it among the larger specialty-retail names and imply the market is paying a moderate premium for earnings quality relative to a typical consumer-discretionary stock. The 9.3% net margin is solid for a retailer that competes across mass and prestige price points, while the 45.4% ROE is notably high. A very high ROE in specialty retail often comes from a combination of lean net-asset intensity and, in some cases, leverage through share buybacks or off-balance-sheet operating leases, so it is worth reading filings to see how that figure is constructed rather than taking it at face value.

The stock’s beta of 0.85 means it has historically moved less than the broad market, which fits the profile of a large, established retailer with recurring customer traffic. At the current price of $544.70, RSI is 52.3 and the 50-day exponential moving average is $525.05, suggesting the stock is near a neutral momentum reading around its short-term trend. Overall, the metrics paint a picture of a profitable, large-cap specialty retailer with a quality bent rather than a deep-value or hyper-growth name.

Strategic Priorities & Outlook

According to the company’s most recent 10-K filing, Ulta Beauty has organized its strategy around three themes: driving core business growth, scaling new accretive businesses, and aligning its foundation for the future.

• Core business growth is centered on operational excellence and an elevated go-to-market approach, including best-in-class store execution, digital acceleration, brand building and merchandising innovation, and enhanced marketing and personalization.
• New growth areas include wellness, the UB Marketplace platform, international expansion, and UB Media.
• The foundation work focuses on optimizing ways of working, streamlining the cost structure, and building an associate-centered culture.

Operationally, the company is reshaping its store and partnership footprint. It launched UB Marketplace in fiscal 2025 and completed the acquisition of Space NK on July 10, 2025. At the same time, Ulta Beauty and Target mutually agreed not to renew the Ulta Beauty at Target shop-in-shop partnership beyond August 2026. The long-term U.S. store target of more than 1,800 locations frames the domestic expansion story, while Space NK, Mexico, and the Middle East carry the international narrative. How these newer and international ventures convertremains the question that the upcoming quarters may start to answer.

Macro & Geopolitical Exposure

As a Consumer Cyclical/Specialty Retail business, Ulta Beauty is exposed to the health of U.S. discretionary spending. Beauty is less cyclical than some retail categories, but sales of cosmetics, skincare, and salon services still depend on consumer confidence, wage growth, employment levels, and household savings. A pullback in discretionary budgets can pressure traffic and product mix.

International operations add currency and geopolitical exposure. Revenue earned in the U.K., Ireland, Mexico, and the Middle East can fluctuate with exchange rates, while local tariff, regulatory, and franchise rules affect profitability. Because the company imports a meaningful share of its merchandise and packaging, changes in trade policy, tariffs on Chinese or other foreign-origin goods, freight costs, and supply-chain disruptions are relevant variables. There is also regulatory risk around cosmetics ingredients, labeling, animal testing, and environmental claims both in the U.S. and abroad. Inventory markdown risk is another standard concern for specialty retailers if demand softens or product trends shift.

Recent Developments

Recent news flow has highlighted Ulta among analyst research calls. On September 15, 2026, Zacks.com published “Why Ulta Beauty (ULTA) is a Top Momentum Stock for the Long-Term,” Benzinga.com ran “This Ulta Beauty Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday,” and 247WallSt.com included the stock alongside a broad list of ticker covered in its “Tuesday’s Top Wall Street Analyst Research Calls” article. The dataset also included a September 16, 2026, GuruFocus.com article on Adagio Medical, which was unrelated to Ulta. None of these headlines provide specific target prices in the data provided, but they do show that sell-side attention on ULTA picked up in mid-September.

Earnings Behavior & Post-Earnings Drift

Ulta Beauty has a strong recent earnings record, but the price reaction pattern is more nuanced. Over the last eight reported quarters, the company beat the market’s real expectation seven times, for an 88% beat rate, and the average earnings surprise was 11.1%. However, the average five-day post-earnings drift across those quarters was -0.91%, classified as a downward drift. In other words, beating estimates has not automatically produced sustained upside.

The most recent four quarters illustrate the dynamic clearly:

• On August 27, 2026, Ulta reported actual EPS of $6.55 versus an estimate of $6.22, a 5.3% surprise. The stock fell 4.18% the next day, but it recovered to post a 3.15% gain over the following five days.
• On June 2, 2026, actual EPS came in at $7.74 versus $6.89 estimated, a 12.3% beat. Despite that, the stock dropped 4.78% the next day and was down 3.43% over the next five days.
• On March 12, 2026, actual EPS of $8.01 missed the $8.10 estimate by 1.1%. The reaction was severe: -14.24% the next day and -14.5% over the following five days.
• On December 4, 2025, actual EPS was $5.14 versus an estimate of $4.61, an 11.5% beat. The stock rose 12.65% the next day and 11.14% over the next five days.

The takeaway is that the unofficial consensus has proven beatable, yet the stock often sells the news. The next scheduled report is December 3, 2026, after the close, with a consensus EPS estimate of $5.60. That figure is below the prior two reports ($6.55 and $7.74), which reflects seasonality rather than necessarily a deterioration in expectations.

For a deeper view of how analysts and institutions are interpreting these numbers, product moves, and the upcoming December 3, 2026 earnings report, the full institutional verdict is worth reviewing as a next step in your analysis.